wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-510CE88B-126C-400B-ADE8-0841316F5E29
Q37604501-510CE88B-126C-400B-ADE8-0841316F5E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-510CE88B-126C-400B-ADE8-0841316F5E29
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P2860
Q37604501-510CE88B-126C-400B-ADE8-0841316F5E29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-510CE88B-126C-400B-ADE8-0841316F5E29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f30388c170bc2d9f5f8d6741cba5d47e45c86182
P2860
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.